Omeros Corporation
(NASDAQ : OMER)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
2.31%186.671.1%$893.59m
GILDGilead Sciences, Inc.
1.90%80.910.9%$837.97m
CELGCelgene Corporation
1.95%95.611.2%$687.44m
BIIBBiogen Inc.
2.80%292.781.2%$564.73m
JUNOJuno Therapeutics, Inc.
0.02%86.5813.5%$436.33m
REGNRegeneron Pharmaceuticals, Inc.
2.55%323.862.7%$403.87m
VRTXVertex Pharmaceuticals Incorporated
5.27%165.901.9%$348.24m
ALXNAlexion Pharmaceuticals, Inc.
3.79%118.932.0%$257.26m
NKTRNektar Therapeutics
1.58%89.606.0%$256.22m
ILMNIllumina, Inc.
3.13%233.843.5%$231.09m
AAgilent Technologies, Inc.
0.03%70.701.5%$186.84m
BLUEBluebird Bio, Inc.
2.41%206.0516.1%$156.27m
INCYIncyte Corporation
3.06%87.802.5%$152.45m
EXASExact Sciences Corporation
-5.82%42.3726.0%$117.22m
BMRNBioMarin Pharmaceutical Inc.
-1.13%83.054.4%$116.68m

Company Profile

Omeros Corp. operates as a biopharmaceutical company specializes in discovery, development, and commercializes of both small-molecule and protein therapeutics for large -market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.